SC
CHRS icon

Shay Capital’s Coherus Oncology CHRS Stock Holding History

Shay Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Hold
105,326
– – 0.01% 425
2026
Q1 		$178K Buy
+105,326
New +$187K 0.01% 398
2025
Q3 		– Sell
-10,296
Closed -$7.53K – 429
2025
Q2 		$7.53K Hold
10,296
– – ﹤0.01% 306
2025
Q1 		$8.31K Hold
10,296
– – ﹤0.01% 301
2024
Q4 		$14.2K Buy
+10,296
New +$11.6K ﹤0.01% 295

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Shay Capital's CHRS Position: Q2 2026 in Review

Shay Capital held its Coherus Oncology (CHRS) position steady in Q2 2026 at 105,326 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #425.

Shay Capital first reported a position in CHRS in Q4 2024 and has held it in 5 quarters since. The position peaked at $178K in Q1 2026. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Shay Capital held 105,326 shares of Coherus Oncology worth $147K as of Q2 2026.
  • Shay Capital left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up 0.01% of Shay Capital's portfolio in Q2 2026, its #425 holding.
  • Shay Capital first reported a position in Coherus Oncology in Q4 2024 and has held it in 5 quarters since.
  • Shay Capital's Coherus Oncology position peaked at $178K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.